Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03100799 · ClinicalTrials.gov registry record · NA
An Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Osteoarthritis of the Knee
A NA study, sponsored by Unity Biotechnology.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03100799 is a NA study that has completed, run by Unity Biotechnology. The registered enrollment target is 30 participants.
The verdict
NCT03100799, a NA study, has completed, sponsored by Unity Biotechnology.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is an exploratory non-drug, interventional biomarker study in approximately 30 eligible patients with active osteoarthritis to investigate the degree of senescence-associated disease. Patients will provide blood and urine and undergo MRI imaging with and without gadolinium enhancement. Following imaging, arthrocentesis of both knees and an arthroscopy of the target knee will occur to obtain fluid, synovium and cartilage for analysis.
Interventions
- DIAGNOSTIC_TEST MRI
- PROCEDURE Arthroscopy
- PROCEDURE Arthrocentesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-02 |
| Est. Completion | 2017-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03100799
The ClinicalTrials.gov registry entry for NCT03100799 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Unity Biotechnology, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MRI is the first listed.
NCT03100799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03100799 about?
NCT03100799 is a clinical study titled "An Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Osteoarthritis of the Knee". This is an exploratory non-drug, interventional biomarker study in approximately 30 eligible patients with active osteoarthritis to investigate the degree of senescence-associated disease. Patients will provide blood and urine and undergo MRI imaging with and without gadolinium enhancement. Followin...
What is the current status of trial NCT03100799?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-03-02. Estimated completion is 2017-07-10.
What interventions are being tested in trial NCT03100799?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST), Arthroscopy (PROCEDURE), Arthrocentesis (PROCEDURE).
Who is sponsoring clinical trial NCT03100799?
This trial is sponsored by Unity Biotechnology, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.